文献速递咽喉与嗓音头颈外科

成人获得性腭咽闭合不全的治疗管理:系统综述与荟萃分析

Management of Acquired Velopharyngeal Insufficiency in Adults: A Systematic Review and Meta-Analysis.
PubMed 文献 · Laryngoscope · 2026-10-15

该系统综述与荟萃分析纳入11项研究共107名成人获得性腭咽闭合不全患者,评估各类干预措施的言语和吞咽结局。荟萃分析显示所有干预后言语改善率为88%(95%CI 78%-94%),吞咽改善率为78%(95%CI 49%-93%);注射咽成形术是最常用干预(82.2%),不良事件率低(5.2%)。

要点

  • 成人获得性腭咽闭合不全多发生于头颈癌治疗后(45%)或神经系统疾病(47%)。
  • 注射咽成形术是最常用干预(82.2%),言语和吞咽改善率分别为88%和71%。
  • 所有干预的言语改善率为88%(95%CI 78%-94%),吞咽改善率为78%(95%CI 49%-93%)。

核心结论

  • 成人获得性腭咽闭合不全高度可治,多数患者经干预后言语和吞咽功能改善。
  • 证据受样本量小和结局报告异质性限制,需前瞻性对照研究以明确最佳治疗选择。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed/MEDLINE、Embase、Web of Science和Cochrane Library从2005年1月至2025年10月发表的研究。
  • 纳入标准为评估成人(≥18岁)腭咽闭合不全干预措施并报告言语和/或吞咽结局的研究。
  • 共筛选1167条记录,最终纳入11项研究,代表107名成人和163次干预。
  • 采用随机效应荟萃分析,基于logit转换的合并比例确定言语和吞咽改善率。

主要发现

  • 腭咽闭合不全最常发生于头颈癌治疗后(45%)或神经系统疾病(47%)。
  • 63.5%的患者为小至中度腭咽闭合不全。
  • 注射咽成形术是最常用干预(82.2%),其次为腭提升修复体(7.4%)和手术重建(5.5%)。
  • 所有干预的言语改善率为88%(95%CI 78%-94%),吞咽改善率为78%(95%CI 49%-93%)。
  • 注射咽成形术患者的言语改善率为88%(95%CI 73%-95%),吞咽改善率为71%(95%CI 34%-92%),不良事件率为5.2%。

临床怎么用

  • 对成人获得性腭咽闭合不全,注射咽成形术是常用且有效的干预选择,不良事件率低。
  • 治疗决策需考虑病因(头颈癌治疗或神经系统疾病)及腭咽闭合不全严重程度。

局限性

  • 纳入研究样本量小。
  • 结局报告异质性大。
  • 缺乏前瞻性对照研究,证据等级有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate treatment outcomes for non-cleft, acquired velopharyngeal insufficiency (VPI) in adults and synthesize the efficacy and safety of available interventions. DATA SOURCES: PubMed/MEDLINE, Embase, Web of Science, and Cochrane Library were searched for studies published from January 2005 to October 2025. REVIEW METHODS: Studies were included if they evaluated interventions with speech and/or swallow outcomes in adults (≥ 18 years) with VPI. Two reviewers independently screened studies, extracted data, and assessed quality. Random-effects meta-analysis using logit-transformed pooled proportions determined rates of speech and swallowing improvement. RESULTS: Of 1167 records screened, 11 studies met inclusion criteria, representing 107 adults and 163 interventions. VPI most occurred after head and neck cancer treatment (45%) or neurologic disease (47%). 63.5% had small to moderate VPI. Injection pharyngoplasty (IP) was the most frequently used intervention (82.2%), followed by palatal lift prosthesis (7.4%) and surgical reconstruction (5.5%). Meta-analysis demonstrated improved speech and swallow in 88% (95% CI: 78%-94%) and 78% (95% CI: 49%-93%) across all interventions, and in 88% (95% CI: 73%-95%) and 71% (95% CI: 34%-92%) in IP patients, respectively. IP is effective and has a low 5.2% adverse events rate. CONCLUSION: Acquired VPI in adults is highly treatable, with most patients experiencing improvement in speech and swallowing across interventions. However, evidence remains limited by small sample sizes and heterogeneous outcome reporting. Prospective and comparative studies using standardized diagnostic criteria and uniform outcome measures are required to better define optimal treatment selection for this adult population. LEVEL OF EVIDENCE: N/A.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Kothari DS, Abiri A, Clair JM, et al. Management of Acquired Velopharyngeal Insufficiency in Adults: A Systematic Review and Meta-Analysis. Laryngoscope. 2026. PMID: 42878437. doi:10.1002/lary.70978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。